Biomedical Engineering Reference
In-Depth Information
79. Foster WM, Langenback EG, Bergofsky EH. Lung mucociliary function in
man: interdependence of bronchial and tracheal mucus transport velocities
with lung clearance in bronchial asthma and healthy subjects. Ann Occup
Hyg 1982; 26(1-4):227-244.
80. Yeates DB, Spektor DM, Pitt BR. Effect of orally administered orciprenaline
on tracheobronchial mucociliary clearance. Eur J Respir Dis 1986; 69(2):
100-108.
81. Bennett WD. Effect of beta-adrenergic agonists on mucociliary clearance.
J Allergy Clin Immunol 2002; 110(6):S291-S297.
82. Tamaoki J, Kondo M, Takizawa T. Effect of cAMP on ciliary function in
rabbit tracheal epithelial cells. J Appl Physiol 1989; 66(3):1035-1039.
83. Devalia JL, Sapsford RJ, Rusznak C, Toumbis MJ, Davies RJ. The effects of
salmeterol and salbutamol on ciliary beat frequency of cultured human bron-
chial epithelial cells, in vitro. Pulm Pharmacol 1992; 5(4):257-263.
84. Wanner A. Effects of methylxanthines on airway mucociliary function. Am J
Med 1985; 79(6A):16-21.
85. Perry RJ, Smaldone GC. Effect of bronchodilators on mucociliary clearance
in normal adults. J Aerosol Med 1990; 3:187-196.
86. Hasani A, Toms N, O'Connor J, Dilworth JP, Agnew JE. Effect of salmeterol
xinafoate on lung mucociliary clearance in patients with asthma. Respir Med
2003; 97(6):667-671.
87. Melloni B, Germouty J. [The influence of a new beta agonist: formoterol on
mucociliary function]. Influence sur la fonction muco-ciliaire d'un nouveau
beta-agoniste:formoterol. Rev Mal Respir 1992; 9(5):503-507.
88. Rogers DF. Airway goblet cells: responsive and adaptable front-line defen-
ders. Eur Respir J 1994; 7(9):1690-1706.
89. National Institutes of Health. Global Initiative for Asthma: pocket guide for
asthma management and prevention. Publication no. 02-3659. 2002.
Bethesda, National Institutes of Health, National Heart, Lung and Blood
Institute.
90. Barnes PJ. Therapy of chronic obstructive pulmonary disease. Pharmacol
Ther 2003; 97(l):87-94.
91. Tamaoki J, Chiyotani A, Kobayashi K, Sakai N, Kanemura T, Takizawa T.
Effect of indomethacin on bronchorrhea in patients with chronic bronchitis,
diffuse panbronchiolitis, or bronchiectasis. Am Rev Respir Dis 1992;
145(3):548-552.
92. Barnes PJ. Scientific rationale for inhaled combination therapy with long-
acting beta2-agonists and corticosteroids. Eur Respir J 2002; 19(1):182-191.
93. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary manage-
ment of chronic obstructive pulmonary disease: scientific review. JAMA
2003; 290(17):2301-2312.
94. Donnelly LE, Rogers DF. Therapy for COPD in the 21st Century. Drugs
2003; 63:1973-1998.
95. Rogers DF. Mucoactive drugs for asthma and COPD: any place in therapy?
Expert Opin Investig Drugs 2002; 11(1):15-35
96. Grandjean EM, Berthet P, Ruffmann R, Leuenberger P. Efficacy of oral long-
term N-acetylcysteine in chronic bronchopulmonary disease: a meta-analysis
